设为首页 | 加入收藏| 旧站地址

扫描下面的二维码：

二维码

资讯

Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(4): 【详细】; 作者：发表时间：2007-11-14 14:29标签：现场快报现场快报肝纤维化

Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(3): 【详细】; 作者：发表时间：2007-11-14 14:28标签：现场快报现场快报肝纤维化

Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(1): 【详细】; 作者：发表时间：2007-11-14 14:27标签：现场快报现场快报肝纤维化

Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(2): 【详细】; 作者：发表时间：2007-11-14 14:27标签：现场快报现场快报肝纤维化

Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (5): 【详细】; 作者：发表时间：2007-11-14 14:25标签：现场快报现场快报其他肝病

Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (4): 【详细】; 作者：发表时间：2007-11-14 14:24标签：现场快报现场快报其他肝病

Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (3): 【详细】; 作者：发表时间：2007-11-14 14:23标签：现场快报现场快报其他肝病

Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (2): 【详细】; 作者：发表时间：2007-11-14 14:22标签：现场快报现场快报其他肝病

Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (1): 【详细】; 作者：发表时间：2007-11-14 14:21标签：现场快报现场快报其他肝病

THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(4): 【详细】; 作者：发表时间：2007-11-14 10:57标签：现场快报现场快报病毒性肝炎

THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(2): 【详细】; 作者：发表时间：2007-11-14 10:56标签：现场快报现场快报病毒性肝炎

THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(3): 【详细】; 作者：发表时间：2007-11-14 10:56标签：现场快报现场快报病毒性肝炎

THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(1): 【详细】; 作者：发表时间：2007-11-14 10:55标签：现场快报现场快报病毒性肝炎

U.S. MULTICENTER PILOT STUDY OF DAILY CONSENSUS INTERFERON (INFERGEN) PLUS RIBAVIRIN FOR (1): 【详细】; 作者：发表时间：2007-11-14 10:53标签：现场快报现场快报病毒性肝炎

U.S. MULTICENTER PILOT STUDY OF DAILY CONSENSUS INTERFERON (INFERGEN) PLUS RIBAVIRIN FOR (2): 【详细】; 作者：发表时间：2007-11-14 10:53标签：现场快报现场快报病毒性肝炎

Outcomes in HIV-HCV co-infected genotype 1 patients treated with peginterferon lafa-2a (40KD) (2): 【详细】; 作者：发表时间：2007-11-14 10:50标签：现场快报现场快报病毒性肝炎

Outcomes in HIV-HCV co-infected genotype 1 patients treated with peginterferon lafa-2a (40KD) (3): 【详细】; 作者：发表时间：2007-11-14 10:50标签：现场快报现场快报病毒性肝炎

Outcomes in HIV-HCV co-infected genotype 1 patients treated with peginterferon lafa-2a (40KD) (1): 【详细】; 作者：发表时间：2007-11-14 10:49标签：现场快报现场快报病毒性肝炎

Long-Term, Low-Dose Treatment With Pegylated Interferon alfa-2b Leads to a Significant Reduction (3): 【详细】; 作者：发表时间：2007-11-14 10:47标签：现场快报现场快报乙肝

Long-Term, Low-Dose Treatment With Pegylated Interferon alfa-2b Leads to a Significant Reduction (4): 【详细】; 作者：发表时间：2007-11-14 10:47标签：现场快报现场快报乙肝

首页前十页 591 592 593 594 595 596 597 598 599 600 后十页尾页

推荐标签更多 >>

栏目标签

领域标签

推荐文章